video

Addressing Challenges of NGS Data Interpretation for Hematologic Malignancies

This groundbreaking webinar will discuss how NGS technologies have aided clinicians in the diagnosis and treatment of hematologic cancer.

Multiplexed Mass Spectrometry Solutions for Cancer Proteomics

In this webinar, multiplexing quantitative proteomics for profiling breast cancer patient-derived xenografts will be discussed.
Protein (ubiquitin) molecule (cartoon model). Stylized image.

In-Cell Protein Footprinting: A New Tool for Proteome-Wide Structural Biology

VIEW NOW Broadcast Date: June 26, 2019 Time: 8:00 am PT, 11:00 am ET, 17:00 CET Protein structure must be studied in its native cellular environment, otherwise,...

Liquid Biopsy and ddPCR: A Match with Quality in Mind

In this webinar we will hear how GenQA addresses some of the challenges in providing quality assessments for ctDNA testing.

LeukoVantage: A Quest/QIAGEN Partnership Providing Clinical Insights Into Myeloid Malignancies

In this webinar, we will describe Quest’s LeukoVantage assay, an NGS test designed specifically for detecting clinically relevant variants in myeloid malignancies, and its partnership with N-of-One, a QIAGEN company, for expert interpretation.

Rise of Genomics in Clinical Trials

The challenges of incorporating NGS into clinical trials is being addressed through the adoption of robust technology solutions.

Rethinking Rx-Dx Codevelopment

Codevelopment is an intermittent and uncertain process. Adopting an agnostic approach to the challenges associated with platform and method selection provide added degrees of freedom for strategic development and selection of the most appropriate clinical trial assay.

Unlocking Value in Clinical Diagnostics

Panelists will discuss how to navigate the clinical diagnostic marketplace and what to consider when developing new assays.

How Multi-Omics Profiling Can Redefine Precision Health and Medicine

Coupling relatively routine datasets such as genomes and transcriptomes with newer types produces an “integrative Personal Omics Profile".

Advancing Mass Spectrometry-Based Large-Cohort Proteomics for Precision Medicine

Large cohort studies are essential to the discovery of protein biomarkers, and their validation is indispensable to clinical utility.
Scroll Up